McIver, Katharine2021-05-112021-05-112021-05-01https://hdl.handle.net/2097/41528West Nile Virus (WNV) is a disease that affects both people and horses as dead-end hosts in a similar manner. Transmitted through the infected bite of a mosquito, manifestation of the disease ranges in severity from being asymptomatic to causing severe encephalitis. Therapy consists largely of supportive care, but the use of antiviral medication, such as interferon alpha-2b (INFa-2b), has been hypothesized to improve outcomes in equine cases. This case report highlights the possible benefits of administration of INFa-2b in the case of a severely neurologic young stallion infected with WNV. Greater understanding of the association of INFa-2b therapy with the outcome of equine WNV cases may provide insight into its potential use in the therapy of human WNV cases.This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).West Nile VirusReport